Alessandro Bertani
Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione
Papers
1
Total Citations
3
H-Index
1
About
Alessandro Bertani is a leading figure in thoracic oncology, with a focused expertise in the surgical and multidisciplinary management of lung cancer. His work centers on optimizing treatment pathways for non-small cell lung cancer (NSCLC), particularly for patients with early and locally advanced stages. Dr. Bertani’s major contribution is his leadership in the Italian Lung Cancer Observational Study (LUCENT), a landmark protocol designed to capture real-world outcomes and evolving treatment paradigms. This initiative, detailed in his most-cited 2024 paper (3 citations), provides critical insights into how surgical, systemic, and radiation therapies are integrated in clinical practice, bridging the gap between clinical trials and everyday patient care. By establishing a comprehensive, multicenter framework, Dr. Bertani is shaping evidence-based guidelines that directly impact survival and quality of life for NSCLC patients. His work underscores a commitment to translating complex data into actionable strategies, making him a pivotal voice in advancing lung cancer research and improving outcomes for this challenging disease.
Research Focus
Key Achievements
Top Papers
- 1